ReviewCurrent cardiology reports2019
Carcinoid Heart Disease: a Comprehensive Review.
Review in Current cardiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 16 citations in OpenAlex.
- Carcinoid Heart Disease.Journal of the advanced practitioner in oncology · 2024Article
- Fine grained automatic left ventricle segmentation via ROI based Tri-Convolutional neural networks.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024Article
- Carcinoid Heart Disease.Radiology. Imaging cancer · 2024Article
- Prevalence, one-year-incidence and predictors of carcinoid heart disease.Cardiovascular ultrasound · 2023Article
- A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.Journal of clinical medicine · 2023Review
- Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease-A Retrospective Study.Journal of clinical medicine · 2023Article
- Multimodality imaging in the diagnostic approach to a patient with carcinoid heart disease involving four heart valves.Clinical case reports · 2022Article
- Cardiac Computed Tomography in Cardio-Oncology:JACC. CardioOncology · 2021Review
- Interventional Strategies in Cancer-induced Cardiovascular Disease.Current oncology reports · 2021Review
- A forgotten diagnosis in right heart failure: A case report and literature review.Clinical case reports · 2021Article
- Electroanatomical mapping- and CT scan image integration-guided pacing lead implantation: A case series and review of the recent literature.Heart rhythm O2 · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewCarcinoid heart disease is a rare disorder that is associated with significant morbidity and mortality. In this review of the literature, we will present current concepts in diagnosis and management of carcinoid heart disease. RECENT
findingsRecent expert consensus guidelines highlight the role of echocardiography and screening with NT-proBNP for the evaluation of carcinoid heart disease. Advances in medical therapy along with better surgical outcomes highlight the experience and expertise that has been gained in the treatment of carcinoid heart disease. Carcinoid heart disease occurs in patients with neuroendocrine tumors who have carcinoid syndrome. Serotonin appears to play a central role in the development of carcinoid heart disease. Cardiac biomarkers and multimodality imaging can be used to aid in screening and diagnosis. The mainstay of treatment of carcinoid heart disease is surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.